Word: fda
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...balding and new vigor to the company's stock. Originally marketed as a treatment for hypertension, minoxidil, in liquid form, was found by 48% of the men in an Upjohn study to produce "moderate-to- dense" hair growth if applied twice daily. Dermatologist Robert Stern, who headed an FDA advisory panel reviewing the drug, finds this a bit misleading. "Under the best circumstances," he says, perhaps 15% would see enough hair growth "to make a visible difference." His panel nonetheless recommended that the agency approve the drug, making it the first hair restorer to receive such an endorsement. Those most...
...cocaine? Presenting Ener-B, an intranasal gel loaded with vitamin B12 and sold in health stores for $12 a twelve-dose box. Like '60s celebrities who swore by B12 shots, enthusiasts claim the new nose job supplies a burst of energy. Absurd, say experts, and the FDA is investigating. Most people have a five- year B12 supply stored in their livers; excess simply gets excreted. "If you buy this gel," sniffs Dr. Victor Herbert of Manhattan's Mount Sinai Medical Center, "you're going to have the most expensive urine in the neighborhood...
...Samuel Broder, who oversees the development of anti-AIDS drugs at the National Cancer Institute in Bethesda, Md. Since that time, he notes, the cause of AIDS has been discovered, the virus cloned, a blood- screening program implemented and development of a vaccine begun. Possibly most remarkable, the FDA is soon expected to approve the first therapeutic drug: azidothymidine (AZT), manufactured by Burroughs Wellcome...
These questions took on new urgency last week when the Anti-Infective Drugs Advisory Committee of the Food and Drug Administration recommended by a 10-1 vote that the FDA approve AZT as the first commercially available treatment for AIDS. The news generated heavy demand from America's 13,000 AIDS victims. For among potential AIDS drugs being tested, only AZT seems to prolong life, specifically for people with Pneumocystis carinii pneumonia (PCP). The prospect of public release intensified ethical concerns surrounding not only drugs for AIDS treatment but also vaccines to prevent...
...long-range effects of AZT, which might be as dangerous as the untreated disease. In fact, some people taking AZT have developed anemia and suffered bone-marrow degeneration. "AZT may be a genie that we are letting out of the bottle," says Dr. Itzhak Brook, chairman of the FDA advisory committee and the only dissenter in the vote. Dr. Maxime Seligmann, a French immunologist who has experimented with AZT at the Hopital St.-Louis in Paris, agrees: "There simply isn't enough knowledge about the benefits of the drug compared to the toxic effects and long-term risks...